Project Grant R03HL185261
Award Date 6/1/26
Completion Date 5/31/28
Dollars Obligated $224K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Birmingham, AL 35294, USA
Similar Awards
- Federal Grant Award Summary The University of Alabama at Birmingham received a $222,750 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded July 21, 2025, with a completion date of June 30, 2027. The grant supports the development of a clinical decision support questionnaire designed to identify barriers to blood pressure control among adults with hypertension. This tool addresses a critical gap in...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Alabama at Birmingham $170,601.00 under the Cardiovascular Diseases Research program (CFDA 93.837) to develop and test a multi-component remote care intervention for rural patients with heart failure. The five-year project, initiated August 1, 2025, and extending through July 31, 2030, addresses the critical health disparity whereby rural populations experience significantly higher...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Alabama at Birmingham $637,732 under the Cardiovascular Diseases Research program (CFDA 93.837) on September 16, 2025, with completion targeted for June 30, 2029. This Project Grant supports research aimed at improving the cardiac microenvironment as a novel therapeutic strategy to address diabetic ischemic heart failure (IHF). The research focuses on leveraging cardiokine...
- Federal Grant Award Summary The University of Alabama at Birmingham received a $162,703 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 15, 2025, with a completion date of July 31, 2030. This project focuses on implementing streamlined, standardized blood pressure (BP) measurement protocols in primary care settings. The award supports research and implementation work to develop and...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Alabama at Birmingham $186,153 under the Cardiovascular Diseases Research program (CFDA 93.837) on September 16, 2025, for a project extending through August 31, 2030. This project grant supports systematic analysis of venous thromboembolism (VTE) data derived from a multicenter prospective cohort study of pediatric VTE patients. The research addresses a critical knowledge gap by...
- Federal Project Grant Award Summary The University of Alabama at Birmingham received a $158,572 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 25, 2025, with completion targeted for August 31, 2030. This research initiative will develop genotypic and phenotypic approaches to identify and characterize individuals with coronary heart disease (CHD) who develop the condition...
- Federal Grant Award Summary The University of Alabama at Birmingham (UAB) received a $1,469,444 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 1, 2025, with completion targeted for May 31, 2030. This clinical research initiative will deliver a randomized controlled trial evaluating the efficacy of disseminating systolic blood pressure (SBP) polygenic risk score (PRS) results in...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Alabama at Birmingham $745,732 under the Cardiovascular Diseases Research program (CFDA 93.837) effective May 1, 2026, through February 28, 2031. This project grant funds the AW-COMPARE study, which compares ambulatory blood pressure monitoring (ABPM) to wrist-worn home blood pressure monitoring (HBPM) devices in assessing end-organ damage related to cardiovascular disease. The...
- Federal Grant Award Summary Boston Children's Hospital received a $279,644 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 1, 2025, with completion scheduled for August 31, 2027. The grant funds research to develop and validate time to return of spontaneous circulation (ROSC) as a novel primary outcome measure for pediatric in-hospital cardiac arrest (P-IHCA) clinical trials. The research...
- Federal Grant Award Summary The University of Alabama at Birmingham received a $180,860 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded April 1, 2026, with completion targeted for March 31, 2029. This hypothesis-driven, patient-oriented pilot randomized clinical trial will evaluate whether providing a high-energy human milk diet enriched with docosahexaenoic acid (DHA) and arachidonic acid (ARA)...